Northwest Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
1,324
-28
| -2% | -$5.2K | 0.13% | 99 |
|
|
2025
Q1 | $283K | Hold |
1,352
| – | – | 0.12% | 98 |
|
|
2024
Q4 | $240K | Sell |
1,352
-75
| -5% | -$13.3K | 0.1% | 93 |
|
|
2024
Q3 | $282K | Hold |
1,427
| – | – | 0.1% | 85 |
|
|
2024
Q2 | $245K | Sell |
1,427
-427
| -23% | -$73.2K | 0.09% | 93 |
|
|
2024
Q1 | $338K | Hold |
1,854
| – | – | 0.11% | 85 |
|
|
2023
Q4 | $287K | Sell |
1,854
-187
| -9% | -$29K | 0.1% | 89 |
|
|
2023
Q3 | $304K | Hold |
2,041
| – | – | 0.12% | 85 |
|
|
2023
Q2 | $275K | Hold |
2,041
| – | – | 0.12% | 88 |
|
|
2023
Q1 | $325K | Buy |
2,041
+345
| +20% | +$55K | 0.16% | 76 |
|
|
2022
Q4 | $274K | Sell |
1,696
-400
| -19% | -$64.6K | 0.15% | 79 |
|
|
2022
Q3 | $281K | Buy |
2,096
+102
| +5% | +$13.7K | 0.16% | 72 |
|
|
2022
Q2 | $305K | Sell |
1,994
-45
| -2% | -$6.88K | 0.16% | 70 |
|
|
2022
Q1 | $331K | Sell |
2,039
-55
| -3% | -$8.93K | 0.16% | 70 |
|
|
2021
Q4 | $295K | Sell |
2,094
-117
| -5% | -$16.5K | 0.14% | 71 |
|
|
2021
Q3 | $241K | Sell |
2,211
-785
| -26% | -$85.6K | 0.13% | 81 |
|
|
2021
Q2 | $348K | Buy |
2,996
+364
| +14% | +$42.3K | 0.2% | 54 |
|
|
2021
Q1 | $285K | Buy |
2,632
+12
| +0.5% | +$1.3K | 0.21% | 47 |
|
|
2020
Q4 | $281K | Buy |
2,620
+12
| +0.5% | +$1.29K | 0.21% | 51 |
|
|
2020
Q3 | $228K | Buy |
2,608
+12
| +0.5% | +$1.05K | 0.19% | 55 |
|
|
2020
Q2 | $255K | Buy |
+2,596
| New | +$255K | 0.22% | 49 |
|